$KALA
KALA BIO, Inc. Stock $kala

$kala Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000155837022013308 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$420.0K	$2.100M	$1.372M
YoY Change	-86.31%	-31.17%	-57.99%
Cost Of Revenue	$11.00K	$1.774M	$775.0K
YoY Change	-98.79%	74.61%	1.97%
Gross Profit	$409.0K	$326.0K	$597.0K
YoY Change	-81.06%	-83.98%	-76.22%
Gross Profit Margin	97.38%	15.52%	43.51%
Selling, General & Admin	$9.549M	$22.67M	$26.98M
YoY Change	-62.33%	-18.98%	-2.59%
% of Gross Profit	2334.72%	6954.91%	4519.6%
Research & Development	$5.391M	$4.473M	$4.466M
YoY Change	87.12%	44.57%	42.87%
% of Gross Profit	1318.09%	1372.09%	748.07%
Depreciation & Amortization	$151.0K	$149.0K	$157.0K
YoY Change	-41.7%	-41.34%	-36.69%
% of Gross Profit	36.92%	45.71%	26.3%
Operating Expenses	$14.99M	$28.07M	$32.29M
YoY Change	-48.56%	-12.54%	2.24%
Operating Profit	-$14.57M	-$25.97M	-$30.91M
YoY Change	-44.12%	-10.58%	9.18%
Interest Expense	$1.447M	$2.207M	$2.035M
YoY Change	-30.16%	5.55%	-4.95%
% of Operating Profit
Other Income/Expense, Net	$43.64M	-$2.139M	-$2.027M
YoY Change	-2222.67%
Pretax Income	$29.07M	-$28.11M	-$32.94M
YoY Change	-203.36%	-22.98%	8.32%
Income Tax
% Of Pretax Income
Net Earnings	$29.07M	-$28.11M	-$32.94M
YoY Change	-203.36%	-22.98%	8.32%
Net Earnings / Revenue	6922.14%	-1338.62%	-2400.95%
Basic Earnings Per Share	$19.39	-$0.38	-$0.45
Diluted Earnings Per Share	$19.25	-$0.38	-$0.45
COMMON SHARES
Basic Shares Outstanding	73.21M	73.68M	73.64M
Diluted Shares Outstanding	1.510M	73.68M	73.64M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.39M	$44.57M	$70.16M
YoY Change	-57.92%	-70.22%	-55.02%
Cash & Equivalents	$52.39M	$42.57M	$65.17M
Short-Term Investments		$1.999M	$4.992M
Other Short-Term Assets	$32.09M	$25.10M	$4.542M
YoY Change	655.92%	1051.38%	74.69%
Inventory	$0.00	$25.00K	$10.53M
Prepaid Expenses
Receivables	$190.0K	$13.82M	$13.02M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$84.67M	$83.52M	$98.26M
YoY Change	-43.21%	-51.37%	-45.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$517.0K	$891.0K	$2.704M
YoY Change	-83.55%	-73.92%	-11.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$475.0K	$519.0K	$9.230M
YoY Change	-96.67%	-95.81%	-51.93%
Total Long-Term Assets	$1.026M	$1.461M	$13.32M
YoY Change	-97.71%	-96.66%	-73.76%
TOTAL ASSETS
Total Short-Term Assets	$84.67M	$83.52M	$98.26M
Total Long-Term Assets	$1.026M	$1.461M	$13.32M
Total Assets	$85.70M	$84.98M	$111.6M
YoY Change	-55.78%	-60.56%	-51.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.348M	$10.54M	$6.218M
YoY Change	25.71%	270.68%	117.79%
Accrued Expenses	$25.37M	$18.31M	$21.24M
YoY Change	30.33%	-13.87%	40.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$40.24M	$32.89M	$32.76M
YoY Change	47.97%	26.14%	63.88%
LONG-TERM LIABILITIES
Long-Term Debt	$42.64M	$79.80M	$79.36M
YoY Change	-45.67%	2.24%	9.43%
Other Long-Term Liabilities	$3.783M	$3.839M	$4.739M
YoY Change	-85.81%	-85.81%	-82.77%
Total Long-Term Liabilities	$46.43M	$83.64M	$84.10M
YoY Change	-55.85%	-20.43%	-15.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.24M	$32.89M	$32.76M
Total Long-Term Liabilities	$46.43M	$83.64M	$84.10M
Total Liabilities	$86.67M	$116.5M	$116.9M
YoY Change	-34.52%	-11.18%	-2.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$574.4M	-$603.4M	-$575.3M
YoY Change	16.08%	29.3%	33.74%
Common Stock	$1.000K	$73.00K	$73.00K
YoY Change	-98.46%	12.31%	14.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$968.0K	-$31.55M	-$5.284M
YoY Change
Total Liabilities & Shareholders Equity	$85.70M	$84.98M	$111.6M
YoY Change	-55.78%	-60.56%	-51.45%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$29.07M	-$28.11M	-$32.94M
YoY Change	-203.36%	-22.98%	8.32%
Depreciation, Depletion And Amortization	$151.0K	$149.0K	$157.0K
YoY Change	-41.7%	-41.34%	-36.69%
Cash From Operating Activities	-$15.67M	-$25.42M	-$24.09M
YoY Change	-39.94%	17.64%	-26.2%
INVESTING ACTIVITIES
Capital Expenditures	-$38.00K	-$172.0K	-$81.00K
YoY Change	-88.45%	-47.08%	-63.18%
Acquisitions
YoY Change
Other Investing Activities	$64.95M	$3.000M	-$4.992M
YoY Change	1186.12%	-86.96%	-110.35%
Cash From Investing Activities	$64.91M	$2.828M	-$5.073M
YoY Change	1274.94%	-87.53%	-110.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-39.87M	-10.00K	154.0K
YoY Change	-3341.63%	-100.17%	-99.56%
NET CHANGE
Cash From Operating Activities	-15.67M	-25.42M	-24.09M
Cash From Investing Activities	64.91M	2.828M	-5.073M
Cash From Financing Activities	-39.87M	-10.00K	154.0K
Net Change In Cash	9.374M	-22.60M	-29.01M
YoY Change	-146.56%	-427.03%	-157.21%
FREE CASH FLOW
Cash From Operating Activities	-$15.67M	-$25.42M	-$24.09M
Capital Expenditures	-$38.00K	-$172.0K	-$81.00K
Free Cash Flow	-$15.63M	-$25.25M	-$24.01M
YoY Change	-39.32%	18.63%	-25.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72673785
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73676819
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64554506
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73658924
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63113194
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2022Q2	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2021	kala	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
	dei	Entity Central Index Key EntityCentralIndexKey	0001479419
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73676819
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64554506
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73658924
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63113194
	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2022Q2	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2021Q2	us-gaap	Restricted Cash Asset Statement Of Financial Position Extensible List RestrictedCashAssetStatementOfFinancialPositionExtensibleList	http://www.kalarx.com/20220630#RestrictedCashAndOtherAssetsNoncurrent
CY2021	kala	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2022Q2	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2021	kala	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65500275
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72673785
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38150
	dei	Entity Registrant Name EntityRegistrantName	KALA PHARMACEUTICALS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0604595
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1167 Massachusetts Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02476
	dei	City Area Code CityAreaCode	781
	dei	Local Phone Number LocalPhoneNumber	996-5252
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	KALA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73208140
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42569000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92136000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	1999000
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	450000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2042000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13822000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15345000
CY2022Q2	us-gaap	Inventory Net InventoryNet	25000
CY2021Q4	us-gaap	Inventory Net InventoryNet	8639000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2143000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6204000
CY2022Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	22507000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	83515000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	124366000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	891000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2722000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9578000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1299000
CY2022Q2	kala	Restricted Cash And Other Assets Noncurrent RestrictedCashAndOtherAssetsNoncurrent	519000
CY2021Q4	kala	Restricted Cash And Other Assets Noncurrent RestrictedCashAndOtherAssetsNoncurrent	1462000
CY2022Q2	us-gaap	Assets Assets	84976000
CY2021Q4	us-gaap	Assets Assets	139427000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10542000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4899000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18306000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20986000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	52000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	711000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3772000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3817000
CY2022Q2	kala	Deferred Purchase Consideration Current DeferredPurchaseConsiderationCurrent	219000
CY2021Q4	kala	Deferred Purchase Consideration Current DeferredPurchaseConsiderationCurrent	7009000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	32891000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37422000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	548000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	79800000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	78929000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3839000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4841000
CY2021Q4	kala	Deferred Purchase Consideration Non Current DeferredPurchaseConsiderationNonCurrent	883000
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	83639000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	85201000
CY2022Q2	us-gaap	Liabilities Liabilities	116530000
CY2021Q4	us-gaap	Liabilities Liabilities	122623000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49655000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5395000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65500275
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	73000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	66000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	571814000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	559126000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-603440000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-542388000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-31554000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16804000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84976000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139427000
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2100000
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3051000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3472000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6317000
CY2022Q2	kala	Product Revenue Cost ProductRevenueCost	1774000
CY2021Q2	kala	Product Revenue Cost ProductRevenueCost	1016000
	kala	Product Revenue Cost ProductRevenueCost	2549000
	kala	Product Revenue Cost ProductRevenueCost	1771000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22673000
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27986000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	55685000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4473000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8939000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6220000
CY2022Q2	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	789000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-262000
CY2022Q2	kala	Gain On Fair Value Re Measurement Of Contingent Consideration GainOnFairValueReMeasurementOfContingentConsideration	59000
	kala	Gain On Fair Value Re Measurement Of Contingent Consideration GainOnFairValueReMeasurementOfContingentConsideration	1047000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	28072000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	32096000
	us-gaap	Operating Expenses OperatingExpenses	60358000
	us-gaap	Operating Expenses OperatingExpenses	63676000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-25972000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29045000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56886000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57359000
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	68000
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	33000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	76000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	76000
CY2022Q2	us-gaap	Interest Expense InterestExpense	2207000
CY2021Q2	us-gaap	Interest Expense InterestExpense	2091000
	us-gaap	Interest Expense InterestExpense	4242000
	us-gaap	Interest Expense InterestExpense	4232000
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5395000
	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	-1000
	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	-4000
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2139000
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1000
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-7453000
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4166000
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-9551000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28111000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36498000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-61052000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66910000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73676819
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64554506
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73658924
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63113194
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28111000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36498000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-61052000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66910000
CY2022Q2	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	1000
CY2021Q2	kala	Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent	-3000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28110000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36501000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61053000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66914000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5284000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1840000
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-28111000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-31554000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	109792000
CY2021Q2	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	170000
CY2021Q2	kala	Stock Issued During Period Value New Issues At Market StockIssuedDuringPeriodValueNewIssuesAtMarket	6021000
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	64000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4894000
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-36498000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	84270000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16804000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	160000
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7936000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4596000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-262000
	kala	Gain On Fair Value Re Measurement Of Contingent Consideration GainOnFairValueReMeasurementOfContingentConsideration	1047000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	871000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	19000
	us-gaap	Net Income Loss NetIncomeLoss	-61052000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-31554000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	99995000
	kala	Payments Of Stock Issuance Costs At Market Offering PaymentsOfStockIssuanceCostsAtMarketOffering	1161000
	kala	Stock Issued During Period Value New Issues At Market StockIssuedDuringPeriodValueNewIssuesAtMarket	40730000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	248000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	431000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9780000
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4000
	us-gaap	Net Income Loss NetIncomeLoss	-66910000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	84270000
	us-gaap	Profit Loss ProfitLoss	-61052000
	us-gaap	Profit Loss ProfitLoss	-66910000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	306000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	504000
	kala	Non Cash Operating Lease NonCashOperatingLease	403000
	kala	Non Cash Operating Lease NonCashOperatingLease	1118000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5395000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	645000
	us-gaap	Share Based Compensation ShareBasedCompensation	4721000
	us-gaap	Share Based Compensation ShareBasedCompensation	9412000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	27000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-22000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1523000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2255000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3467000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-826000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1584000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5387000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5643000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1250000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2670000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1966000
	kala	Increase Decrease In Lease And Other Liabilities Noncurrent IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent	-324000
	kala	Increase Decrease In Lease And Other Liabilities Noncurrent IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent	-834000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49508000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54248000
	kala	Payments To Acquire Property Plant And Equipment And Other Assets PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets	253000
	kala	Payments To Acquire Property Plant And Equipment And Other Assets PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets	545000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4992000
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	3000000
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	71250000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2245000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	70705000
CY2021Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2218000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	77782000
	kala	Payment Of Principal On Venture Debt Facility PaymentOfPrincipalOnVentureDebtFacility	78010000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40730000
	us-gaap	Interest Paid Net InterestPaidNet	3030000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	424000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	163000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	679000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41164000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-51609000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57621000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94878000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	89756000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43269000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	147377000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43269000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	147377000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	700000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2742000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42569000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	144635000
	kala	Capital Expenditures Incurred But Not Yet Paid Accounts Payable CapitalExpendituresIncurredButNotYetPaidAccountsPayable	139000
	kala	Capital Expenditures Incurred But Not Yet Paid Accounts Payable CapitalExpendituresIncurredButNotYetPaidAccountsPayable	318000
	us-gaap	Interest Paid Net InterestPaidNet	3315000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1218000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-603440000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5480000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6324000
	kala	Investments Contractual Maturity Term InvestmentsContractualMaturityTerm	P1Y
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	7935000
CY2022Q2	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	789000
	kala	Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration	-262000
CY2022Q2	kala	Accrued Commercialization Cost AccruedCommercializationCost	2293000
	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2022Q2	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2021	kala	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2000000
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1999000
CY2021Q4	kala	Accrued Commercialization Cost AccruedCommercializationCost	2134000
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1147000
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	584000
	us-gaap	Variable Lease Cost VariableLeaseCost	626000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	881000
CY2022Q2	kala	Accrued Contract Manufacturing AccruedContractManufacturing	1075000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1328000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	9799000
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7090000
CY2022Q2	kala	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	25000
CY2021Q4	kala	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	18217000
CY2022Q2	us-gaap	Inventory Net InventoryNet	25000
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	19651000
CY2021Q4	us-gaap	Inventory Net InventoryNet	8639000
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9578000
CY2021Q4	kala	Accrued Revenue Reserves AccruedRevenueReserves	10300000
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	179000
CY2022Q2	kala	Accrued Revenue Reserves AccruedRevenueReserves	7320000
CY2021Q4	kala	Accrued Contract Manufacturing AccruedContractManufacturing	396000
CY2022Q2	kala	Development Costs Current DevelopmentCostsCurrent	522000
CY2021Q4	kala	Development Costs Current DevelopmentCostsCurrent	127000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	469000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	824000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18306000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20986000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2042000
	kala	Vehicles Leased Term VehiclesLeasedTerm	P2M
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	450000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	450000
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	219000
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1268000
	us-gaap	Operating Lease Cost OperatingLeaseCost	395000
	us-gaap	Operating Lease Cost OperatingLeaseCost	2484000
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	54000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	94000
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.026
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Variable Lease Cost VariableLeaseCost	1093000
CY2022Q2	us-gaap	Lease Cost LeaseCost	452000
CY2021Q2	us-gaap	Lease Cost LeaseCost	1852000
	us-gaap	Lease Cost LeaseCost	1115000
	us-gaap	Lease Cost LeaseCost	3577000
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	251000
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1659000
	us-gaap	Operating Lease Payments OperatingLeasePayments	970000
	us-gaap	Operating Lease Payments OperatingLeasePayments	3243000
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.102
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000000
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000000
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1698000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1927000
CY2022Q2	kala	Debt Instrument Exit Fees Of Total Principal Payments Value DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue	1498000
CY2021Q4	kala	Debt Instrument Exit Fees Of Total Principal Payments Value DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue	856000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	79800000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	78929000
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-61052000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66910000
	kala	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	215172
CY2021	kala	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	215172
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4001408
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4001408
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.729
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.843
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0143
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0336
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.83
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1916000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4710000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4721000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9412000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28111000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36498000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73676819
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64554506
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73658924
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63113194
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13310600
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11541750
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	3033000
CY2022Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	6190000
CY2022Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	6380000
CY2022Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	9370000
CY2022Q2	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	7028000
CY2022Q2	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	14411000
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	46412000
	kala	Minimum Contract Amount Percent MinimumContractAmountPercent	0.75
	kala	Minimum Contract Amount Percent MinimumContractAmountPercent	0.75
CY2022Q2	kala	Number Of Employees To Be Terminated NumberOfEmployeesToBeTerminated	113

Files In Submission

Name	View Source	Status
0001558370-22-013308-index-headers.html	Edgar Link	pending
0001558370-22-013308-index.html	Edgar Link	pending
0001558370-22-013308.txt	Edgar Link	pending
0001558370-22-013308-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kala-20220630.xsd	Edgar Link	pending
kala-20220630x10q.htm	Edgar Link	pending
kala-20220630xex10d1.htm	Edgar Link	pending
kala-20220630xex10d2.htm	Edgar Link	pending
kala-20220630xex31d1.htm	Edgar Link	pending
kala-20220630xex31d2.htm	Edgar Link	pending
kala-20220630xex32d1.htm	Edgar Link	pending
kala-20220630xex32d2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
kala-20220630_lab.xml	Edgar Link	unprocessable
kala-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
kala-20220630_pre.xml	Edgar Link	unprocessable
kala-20220630x10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kala-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KALA
KALA BIO, Inc. Stock $kala

2022 Q3 Form 10-Q Financial Statement

#000155837022013308 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALA KALA BIO, Inc. Stock $kala

2022 Q3 Form 10-Q Financial Statement

#000155837022013308 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALA
KALA BIO, Inc. Stock $kala